NCT00144469View on ClinicalTrials.gov

A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Patients With Chronic Hepatitis C

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

May 31, 2002

Study Completion Date

March 31, 2005

Conditions
Chronic Hepatitis C
Interventions
DRUG

peginterferon alfa-2a

DRUG

rivavirin

Sponsors
All Listed Sponsors
lead

Chugai Pharmaceutical

INDUSTRY

NCT00144469 - A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Patients With Chronic Hepatitis C | Biotech Hunter | Biotech Hunter